About BioSymetrics
BioSymetrics is a Healthcare company based in New York (United States) founded in 2015. Provider of a cognitive computing-based biomedical intelligence platform. It operates in the Healthcare and Technology sectors. BioSymetrics has raised $4.88 million across 1 funding round. BioSymetrics offers products and services including AI Discovery Platform. Its focus areas include Enterprise Infrastructure, Cognitive Computing, Applications and Healthcare and Lifesciences. Its legal entity is LUNFARDA LLC. Its competitors include Atomwise, ScienceIO and MicroHealth; 3 of its 3 listed competitors have raised funding.
Company details
BioSymetrics was founded in 2015 and is based in New York, United States. Operations focus on the biomedical sector, where a platform for cognitive computing is provided. Services include data pre-processing, analytics, and zero-latency machine learning applied to bioinformatics, RD clinical informatics, target discovery, and computational biology. Predictive analytics are also delivered for various RD and healthcare datasets.
- Headquarters New York, United States
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website biosymetrics.com
- Social LinkedIn X
- Legal Name Lunfarda Llc
- Total Equity Funding$4.88M (USD)
in 1 rounds
- Latest Funding Round$4.88M (USD), Series A
Aug 2021
Products & Services of BioSymetrics
BioSymetrics offers a comprehensive portfolio of products and services, including AI Discovery Platform.
Uses machine learning to predict and validate targets for precision medicines
Funding Insights of BioSymetrics
BioSymetrics has successfully raised a total of $4.88M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.88 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.88M
- Total Rounds 1
- Last Round Series A — $4.88M
- First Round $4.88M
(Aug 2021)
All 1 funding rounds of BioSymetrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2021 | $4.88M | Series A | – | – | – |
People of BioSymetrics
13 people are tracked at BioSymetrics (4 in leadership, 7 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Gabriel Musso | Chief Scientific Officer | Leadership |
Victoria Catterson | VP, Research | Leadership |
Michele Arena, PMP | Director Project Management | Leadership |
Kevin Ha | Head of Data Science, Genomics | Leadership |
Frederick Roth | Board Member | Board & advisors |
Gene Salkind | Board Member | Board & advisors |
Paul Boutros | Board Member | Board & advisors |
Jon Chelico | Advisor | Board & advisors |
Yolanda Sanchez | Advisor | Board & advisors |
Calum MacRae | Board Member | Board & advisors |
Robert Devita | Board Member | Board & advisors |
Simon Eng | Senior Data Scientist | Team |
Steven Bishop | Senior Solutions Architect | Team |
Complete people profiles for BioSymetrics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioSymetrics
2 dated milestones of BioSymetrics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded BioSymetrics is founded.
- Funding First funding round of $4.9M.
Competitors of BioSymetrics
BioSymetrics has 3 listed competitors in our database, 3 of them funded. They include Atomwise, ScienceIO and MicroHealth.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atomwise.com | 2012 | San Francisco, United States | $218.64M | 70 | AI-driven platform for structure-based drug discovery is provided. | |
| science.io | 2020 | Boston, United States | $8M | 22 | Provider of AI solutions transforming medical text into enriched healthcare data | |
| microhealth.com | 2010 | New York, United States | $120,000 | 262 | Population health management and care coordination solutions are provided. |
Detailed competitors of BioSymetrics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioSymetrics
The website of BioSymetrics (biosymetrics.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 233.2% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as BioSymetrics (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biosymetrics
Complete news archive for BioSymetrics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioSymetrics
BioSymetrics was founded in 2015 and raised its 1st funding round 6 years after it was founded.
BioSymetrics is headquartered in New York, United States. It is registered at New York, New York, United States.
BioSymetrics is a funded company, having raised a total of $4.88M across 1 funding round to date. The company's 1st funding round was a Series A of $4.88M, raised on Aug 2021.
BioSymetrics was founded in 2015 and is based in New York, United States. Operations focus on the biomedical sector, where a platform for cognitive computing is provided. Services include data pre-processing, analytics, and zero-latency machine learning applied to bioinformatics, RD clinical informatics, target discovery, and computational biology. Predictive analytics are also delivered for various RD and healthcare datasets.
BioSymetrics's top competitors include Atomwise, ScienceIO and MicroHealth.
BioSymetrics offers AI Discovery Platform.
BioSymetrics operates through Lunfarda Llc.